Article metrics

Protocol
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study

 

Online download statistics by month:

Online download statistics by month: May 2021 to December 2024

AbstractFullPdf
May 202138839358
Jun 2021594596152
Jul 202133233855
Aug 202126026264
Sep 202125024971
Oct 202128629088
Nov 202121721366
Dec 202124925456
Jan 202222422049
Feb 202217518145
Mar 202226927473
Apr 202223723897
May 202222222564
Jun 202216216549
Jul 202216316053
Aug 202215816647
Sep 202211311232
Oct 202212312248
Nov 202213913274
Dec 202220219451
Jan 202349549070
Feb 202316616048
Mar 202318418056
Apr 202315915756
May 202315014866
Jun 202313913141
Jul 202310410037
Aug 202313712946
Sep 202313212851
Oct 202311710756
Nov 202315512534
Dec 202317917688
Jan 202413310351
Feb 202416314846
Mar 2024183155103
Apr 2024217199154
May 2024188177108
Jun 2024146139105
Jul 2024207192122
Aug 202419918395
Sep 202418415480
Oct 202418017172
Nov 202416015574
Dec 2024222015
Total886286112966